[MYX] YoY Quarter Result on 31-Dec-2023 [#Q2]

Stock
[MYX] Mayne Pharma Group Limited
Announcement Date
29-Dec-2023
Financial Year
2024
Quarter
31-Dec-2023 [#Q2]
Profit Trend
QoQ- 58.94%
YoY- 51.20%
Quarter Report
MYX's Result
MYX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 187,926 101,165 196,435 208,842 227,152 274,371 243,256 -4.20%
PBT -74,865 -166,537 -63,702 -229,255 -24,960 11,880 -210,843 -15.84%
Tax -4,316 -37,362 -13,105 -47,576 -6,352 10,879 37,707 -
NP -70,552 -144,575 -50,370 -181,286 -17,543 2,580 -174,206 -13.97%
Tax Rate - - - - - -91.57% - -
Total Cost 258,478 245,740 246,805 390,128 244,695 271,791 417,462 -7.67%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -37.54 -142.91 -25.64 -86.81 -7.72 0.94 -71.61 -10.20%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.87 -1.64 -0.62 -2.32 -0.23 0.04 -2.38 -15.43%
EPS Diluted -0.87 -1.64 -0.62 -2.32 -0.23 0.04 -2.38 -15.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.